Skip to main content
Clinical Trials/NCT05410015
NCT05410015
Recruiting
Not Applicable

Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Via Analysis of Immunoinflammation-related Protein Complexes in Blood

Peking Union Medical College Hospital1 site in 1 country300 target enrollmentStarted: February 3, 2022Last updated:
ConditionsOvarian Cancer

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
300
Locations
1
Primary Endpoint
Immune Inflammation-Related Protein Pomplexes

Overview

Brief Summary

The relationship between immune inflammation-related protein complexes inblood and recurrence or metastasis of ovarian cancer will be studied

Detailed Description

100 cases in normal ovarian control group, 100 cases in benign ovarian disease group and 100 cases in malignant ovarian epithelial carcinoma group will be studied. Change regularity of ovarian cancer specific immune inflammation-related protein complexes in blood will be studied. The relationship between disease-specific protein complexes and pathological state of patients will be analyzed.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
20 Years to 70 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Normal ovary control
  • Ovarian benign disease
  • Ovarian malignant epithelial carcinoma

Exclusion Criteria

  • Age above 70
  • Suffering from other malignant tumors
  • Non-compliant patient

Outcomes

Primary Outcomes

Immune Inflammation-Related Protein Pomplexes

Time Frame: 2 years

The change of immune inflammation-related protein complexes

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials